Use Misoprostol to Optimize Prevention of Cervical Cancer
ConditionCervical Cancers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25+
SponsorUniversity of Alabama at Birmingham
About this trial
This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.
Eligibility criteria
Qualifiers
Diagnosis of Type 3 TZ confirmed on exam prior to randomization
Age 25 years or older
Disqualifiers
With Type 1 or 2 TZ prior to randomization
Currently pregnant
History of hysterectomy
Any cancerous lesions
Trial design
Treatments tested in this trial
- Placebo
- Misoprostol
Treatment groups
420 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
Cameroon Baptist Convention Health
Collaborator
Source ClinicalTrials.gov